Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sana Biotechnology, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
SANA
Nasdaq
2836
www.sana.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sana Biotechnology, Inc.
Assessing Sana Biotechnology (SANA) Valuation After Recent Share Price Momentum
- Jan 8th, 2026 12:13 pm
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Jan 7th, 2026 2:26 pm
Three Genomics Stocks Worth Tracking This Year
- Jan 6th, 2026 5:06 am
Sana Biotechnology Showcases Successful In Vivo Gene Editing of Stem Cells in Nature Publication
- Dec 28th, 2025 8:05 am
Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform
- Dec 8th, 2025 7:00 am
Will Sana Biotechnology’s (SANA) Pipeline Focus Reveal Strategic Priorities in Diabetes and Autoimmune Innovation?
- Dec 1st, 2025 12:05 am
Sana Biotechnology (SANA): Assessing Valuation After Strong Year-to-Date Share Price Gains
- Nov 30th, 2025 8:07 am
Sana (SANA) Surges 14.5% Ahead of Business Announcements
- Nov 28th, 2025 8:11 am
Sana Biotechnology to Present at December 2025 Investor Conferences
- Nov 24th, 2025 2:05 pm
Top 3 Genomics Stocks to Consider for Your Portfolio
- Nov 18th, 2025 6:48 am
Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength
- Nov 18th, 2025 4:17 am
Can Sana Biotechnology’s (SANA) Leaner Cost Structure Strengthen Its Long-Term Competitive Position?
- Nov 16th, 2025 5:13 pm
All You Need to Know About Sana (SANA) Rating Upgrade to Buy
- Nov 12th, 2025 10:00 am
Assessing Sana Biotechnology’s (SANA) Valuation After Strategic Refocus and Encouraging Clinical Updates
- Nov 9th, 2025 12:06 am
Sana: Q3 Earnings Snapshot
- Nov 6th, 2025 2:26 pm
Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates
- Nov 6th, 2025 2:05 pm
Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit
- Nov 4th, 2025 2:05 pm
Progressive stock sinks on Q3 miss, gold hits yet another record
- Oct 15th, 2025 10:07 am
Sana Biotechnology stock higher after Eric Jackson touts 100-bagger potential
- Oct 15th, 2025 8:45 am
Sana Biotechnology (SANA): Evaluating Valuation Following Recent 47% Share Price Surge
- Oct 9th, 2025 9:12 pm
Scroll